entertainment -WSS

entertainment

author：comprehensive 2025-09-27 09:46:29 - browse：9423

STAT's Casey Ross (left) and Kimberly Powell, NVIDIA's vice president for healthcare at the STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by a single-mile marker: When will we get an AI-designed drug?

The answer remains, ambiguously, “the future,” but at STAT’s Breakthrough Summit leaders from NVIDIA and Google insisted that the impact of AI is visible today.

Kimberly Powell, vice president of healthcare for NVIDIA, pointed to an increase in investigational new drug applications filed with the Food and Drug Administration that cite AI, as well as an uptick in early-stage readouts from clinical trials, as evidence of progress. Some of the recent readouts, Powell said, show that what’s going into Phase 1 clinical trials is more successful.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Weight bias in eating disorder treatment complicated by new weight loss drugs

hotspot

WSS

#NeedHerScience: shining a light on gender disparities in medicine

Disclosing genetic information: not as worrisome as once feared

New weight loss drugs vying to be the next Wegovy or Mounjaro

Why drug prescriptions should include diagnoses

#NeedHerScience: shining a light on gender disparities in medicine

White House touts steps to stem shortages of cancer treatments

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Tori Bowie and the unacceptable rates of Black maternal death

Cloning humans is technically possible. It's curious no one has tried

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Will the IRA bring competition to the biologics market?

Activists slam private health insurers over coverage restrictions

Paxlovid study fails to answer questions over benefit for broader groups

The cancer drug shortage isn’t new — and neither are the solutions

Regeneron agrees to White House price limits on anti

Duchenne breakthrough therapy leaves behind pioneering families

#NeedHerScience: shining a light on gender disparities in medicine

focus

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Telehealth for opioid use disorder is lifesaving

WATCH: Why do fingernails fall off when they're damaged?

Generate Biomedicines machine learning biotech raises $273M

Paxlovid study fails to answer questions over benefit for broader groups

Popular nasal decongestant doesn't actually relieve congestion

hotspot

hotspot

Wikipedia

entertainment